{"name": "Symphogen",
 "permalink": "symphogen",
 "crunchbase_url": "http://www.crunchbase.com/company/symphogen",
 "homepage_url": "http://www.symphogen.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@symphogen.com",
 "phone_number": "+45 4526 5050",
 "description": "Recombinant polyclonal antibodies ",
 "created_at": "Fri Apr 17 12:25:48 UTC 2009",
 "updated_at": "Tue May 07 10:53:06 UTC 2013",
 "overview": "\u003Cp\u003ESymphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       61],
      "assets/images/resized/0004/1671/41671v1-max-150x150.png"],
     [[194,
       79],
      "assets/images/resized/0004/1671/41671v1-max-250x250.png"],
     [[194,
       79],
      "assets/images/resized/0004/1671/41671v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder and CFO",
    "person":
     {"first_name": "Thomas",
      "last_name": "Feldthus",
      "permalink": "thomas-feldthus",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0004/5647/45647v1-max-150x150.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5647/45647v1-max-250x250.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5647/45647v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-founder and CEO",
    "person":
     {"first_name": "Kirsten",
      "last_name": "Drejer",
      "permalink": "kirsten-drejer",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0004/5645/45645v1-max-150x150.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5645/45645v1-max-250x250.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5645/45645v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-founder and CSO",
    "person":
     {"first_name": "John",
      "last_name": "Haurum",
      "permalink": "john-haurum",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0004/5646/45646v1-max-150x150.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5646/45646v1-max-250x250.jpg"],
          [[180,
            240],
           "assets/images/resized/0004/5646/45646v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac334M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.symphogen.com/web/guest/newsarchive/readmore?p_p_id=56_INSTANCE_ZUuU\u0026articleId=90",
    "source_description": "Symphogen secures \u00e2\u201a\u00ac 33 million financing to support clinical development of antibody products",
    "raised_amount": 33000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2009,
    "funded_month": 2,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 6,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "GenenFUND",
         "permalink": "genenfund",
         "image": null},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://bulletin.sciencebusiness.net/sb/login.php?page=/ebulletins/showissue.php3?page=/548/art/4700",
    "source_description": "Symphogen gets $25M for clinical trials for bleeding treatment",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 1,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Takeda Research Investment",
         "permalink": "takeda-research-investment",
         "image":
          {"available_sizes":
            [[[89,
               45],
              "assets/images/resized/0008/4399/84399v1-max-150x150.jpg"],
             [[89,
               45],
              "assets/images/resized/0008/4399/84399v1-max-250x250.jpg"],
             [[89,
               45],
              "assets/images/resized/0008/4399/84399v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LD Pensions",
         "permalink": "ld-pensions",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0006/8573/68573v1-max-150x150.png"],
             [[250,
               53],
              "assets/images/resized/0006/8573/68573v1-max-250x250.png"],
             [[330,
               70],
              "assets/images/resized/0006/8573/68573v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Scandinavian Life Science Venture",
         "permalink": "scandinavian-life-science-venture-2",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0010/3593/103593v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0010/3593/103593v1-max-250x250.png"],
             [[250,
               47],
              "assets/images/resized/0010/3593/103593v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vaekstfonden",
         "permalink": "vaekstfonden",
         "image":
          {"available_sizes":
            [[[150,
               8],
              "assets/images/resized/0004/9946/49946v1-max-150x150.png"],
             [[200,
               11],
              "assets/images/resized/0004/9946/49946v1-max-250x250.png"],
             [[200,
               11],
              "assets/images/resized/0004/9946/49946v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/01/symphogen-closes-100m-round-of.html",
    "source_description": "Symphogen Closes \u00e2\u201a\u00ac100M Round of Financing",
    "raised_amount": 100000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Danish Pension Fund PKA",
         "permalink": "the-danish-pension-fund-pka",
         "image":
          {"available_sizes":
            [[[60,
               98],
              "assets/images/resized/0027/0180/270180v1-max-150x150.png"],
             [[60,
               98],
              "assets/images/resized/0027/0180/270180v1-max-250x250.png"],
             [[60,
               98],
              "assets/images/resized/0027/0180/270180v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "f",
    "source_url": "http://onbiovc.com/symphogen-as-series-f-1354m/",
    "source_description": "Symphogen, AS: Series F $135.4M",
    "raised_amount": 135400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://www.finsmes.com/2013/05/symphogen-closes-additional-e41m-financing.html",
    "source_description": "Symphogen Closes Additional \u20ac41M Financing",
    "raised_amount": 41000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "PKA",
         "permalink": "pka",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Danica Pension",
         "permalink": "danica-pension",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Symphogen A/S",
    "address1": "Elektrovej Building 375",
    "address2": "",
    "zip_code": "DK-2800",
    "city": "Lyngby",
    "state_code": null,
    "country_code": "DNK",
    "latitude": 55.783256,
    "longitude": 12.515066}],
 "milestones":
  [{"description": "Symphogen lines up record $131M venture round.",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 6,
    "source_url": "http://www.fiercebiotech.com/story/symphogen-lines-record-131m-venture-round/2011-01-06?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Symphogen lines up record $131M venture round",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Symphogen",
      "permalink": "symphogen"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        96],
       "assets/images/resized/0004/3928/43928v1-max-150x150.jpg"],
      [[250,
        161],
       "assets/images/resized/0004/3928/43928v1-max-250x250.jpg"],
      [[450,
        290],
       "assets/images/resized/0004/3928/43928v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}